Background illustration for clinical trials search

Paid Clinical Trials Fort Worth

Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

for
Solid Tumours
Location: Fort Worth TX, San Antonio TX, Sioux Falls SD,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07160725

Phase 1, Phase 2, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer
Location: Fort Worth TX, Round Rock TX, Shreveport LA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06692738

Phase 3, Recruiting

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

for
Biliary Tract Cancer
Location: Fort Worth TX, Dallas TX, Houston TX, Kansas City MO,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06467357

Phase 3, Recruiting

A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

for
Renal Insufficiency, Chronic
Location: Fort Worth TX, Stephenville TX, Sugar Land TX,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07624305

Phase 3, Recruiting

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

for
ER-Positive HER2-Negative Breast Cancer
Location: Fort Worth TX, Kingwood TX, Marietta GA, Edgewood KY
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07647328

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis

for
CKD, Metabolic Acidosis
Location: Fort Worth TX, Houston TX, San Antonio TX, Van Vleck TX,
Sponsor: Renibus Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07355062

Phase 3, Recruiting

WRAP North America

for
Venous Stenosis, Venous Occlusion
Location: Fort Worth TX, Humble TX, Dothan AL, Lexington KY,
Sponsor: Merit Medical Systems, Inc.

Sex: All

Age: 18+

Code: NCT06807099

Recruiting

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Fort Worth TX, Mansfield TX, Dallas TX,
Sponsor: AstraZeneca

Sex: All

Age: 40 - 70+

Code: NCT06883305

Phase 3, Recruiting

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for
Non-Small Cell Lung Cancer
Location: Fort Worth TX, Kingwood TX, Houston TX, Odessa TX,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06357533

Phase 3, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for
Non-squamous Non-small Cell Lung Cancer
Location: Fort Worth TX, Irving TX, Palestine TX, Round Rock TX,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06627647

Phase 3, Recruiting

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

for
Endometrial Cancer
Location: Fort Worth TX, Austin TX, Shreveport LA, San Antonio TX,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT06989112

Phase 3, Recruiting

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

for
Adenocarcinoma, Carcinoma, Pancreatic Ductal
Location: Fort Worth TX, San Antonio TX, Westwood KS,
Sponsor: Corcept Therapeutics

Sex: All

Age: 18+

Code: NCT07259317

Phase 2, Recruiting

Obalon Navigation/Touch System Post-Approval Study

for
Obesity
Location: Fort Worth TX, Flower Mound TX
Sponsor: Obalon Therapeutics, Inc.

Sex: All

Age: 22+

Code: NCT04095481

Recruiting

Clinical Data Registry of Amblyopia Patients on Luminopia Treatment

for
Amblyopia
Location: Fort Worth TX, Crestview FL, Indianapolis IN,
Sponsor: Luminopia

Sex: All

Age: 0+

Code: NCT06429280

Recruiting

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

for
Amblyopia
Location: Fort Worth TX, Oklahoma City OK, San Antonio TX,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 3 - 13

Code: NCT04378790

Phase 3, Recruiting

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer,
Location: Fort Worth TX, Fort Lauderdale FL, Arlington TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07222566

Phase 3, Recruiting

A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

for
Low Grade Serous Ovarian Cancer
Location: Fort Worth TX, Tyler TX, Austin TX, Oklahoma City OK,
Sponsor: Verastem, Inc.

Sex: Female

Age: 18+

Code: NCT06072781

Phase 3, Recruiting

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for
Melanoma
Location: Fort Worth TX, Bedford TX, Grapevine TX, Dallas TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06246916

Phase 3, Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

for
High Grade Epithelial Ovarian Cancer,
Location: Fort Worth TX, Dallas TX, Tyler TX, Abilene TX,
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT05579366

Phase 1, Phase 2, Recruiting

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Fort Worth TX, Austin TX, San Antonio TX, Tulsa OK,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06824467

Phase 3, Recruiting